INNOVATIVE STRATEGY FOR TREATMENT OF LUNG CANCER: INHALATORY CODELIVERY OF ANTICANCER DRUGS AND SIRNA FOR SUPPRESSION OF CELLULAR RESISTANCE

Rutgers, The State University

Investigators